Quantifying geometric and dosimetric advantage from the use of rectal spacing in HDR prostate brachytherapy
Brachytherapy · 2026
DOI: 10.1016/j.brachy.2025.08.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brachytherapy, 2026. Verfasst von Joel Beaudry und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY; Medical Physics Unit, Department of Oncology, McGill University,…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Brachytherapy, Rectum. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, National Institutes of Health.
Abstract (Originalsprache)
INTRODUCTION: Rectal spacers are used during prostate external beam radiation therapy to increase rectal-prostate separation, thereby reducing rectal dose and toxicity. However, their role in high-dose-rate (HDR) brachytherapy remains less understood. This paper presents (i) a cohort study evaluating the dosimetric impact of rectal spacers in HDR prostate brachytherapy and (ii) a simulation study assessing how rectal-prostate separation affects dosimetry. METHODS: We retrospectively analyzed 157 patients treated with 15 Gy HDR prostate boost brachytherapy. Patients were divided into preimplant spacer (n = 49) and nonspacer (n = 108) cohorts. Prostate and rectal dose-volume histogram (DVH) metrics were compared, and rectal-prostate separation was measured on intraoperative transrectal ultrasound. A custom linear programming optimizer simulated plans with separations of 0.5-12 mm in 30 nonspacer cases to evaluate resulting dose metrics. RESULTS: Mean (± standard deviation) rectal-prostate separation was 7.8 ± 1.4 mm with spacer versus 4.0 ± 1.4 mm without spacer. Rectal dose was significantly reduced with spacer (mean D2cc 7.4 ± 1.0 Gy vs. 9.2 ± 1.0 Gy; p 3 mm consistently achieved prostate D90 > 16 Gy and V100 > 95%, and separations > 4 mm produced a marked reduction in rectal dose. CONCLUSION: Rectal spacers significantly reduce rectal dose in HDR prostate brachytherapy. Patients with rectal-prostate separations of at least 4 mm are most likely to benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY; Medical Physics Unit, Department of Oncology, McGill University, Montreal, Quebec, Canada. Electronic address: beaudrj1@mskcc.org.
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
- Medical Physics Unit, Department of Oncology, McGill University, Montreal, Quebec, Canada; Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.
Förderung
- NCI NIH HHS
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Beaudry, J., Wang, T., Aramburu Núñez, D., Kollmeier, M., Gorovets, D., Enger, S. A., & Damato, A. L. (2026). Quantifying geometric and dosimetric advantage from the use of rectal spacing in HDR prostate brachytherapy. Brachytherapy. https://doi.org/10.1016/j.brachy.2025.08.009
Vancouver
Beaudry J, Wang T, Aramburu Núñez D, Kollmeier M, Gorovets D, Enger SA, et al. Quantifying geometric and dosimetric advantage from the use of rectal spacing in HDR prostate brachytherapy. Brachytherapy. 2026. doi:10.1016/j.brachy.2025.08.009
BibTeX
@article{Beaudry2026,
author = {Beaudry, Joel and Wang, Tonghe and Aramburu Núñez, David and Kollmeier, Marisa and Gorovets, Daniel and Enger, Shirin A and Damato, Antonio L},
title = {Quantifying geometric and dosimetric advantage from the use of rectal spacing in HDR prostate brachytherapy},
journal = {Brachytherapy},
year = {2026},
doi = {10.1016/j.brachy.2025.08.009}
}
EUVIMED